Insider · CIK 0001604351

Bierly Rick

Reports to the SEC for 4 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001604351

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-10-12	OptiNose, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+28.9K sh	—	—	28,879
2017-06-15	ACRSAclaris Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,000 sh	—	—	8,000
2017-05-16	Impax Laboratories, LLCA Award	Director	AAward	+4,375 sh	—	—	9,270
2017-05-16	Impax Laboratories, LLCStock Option (Right-to-Buy)A Award	Director	AAward	+10.6K sh	—	—	10,575
2016-08-19	Impax Laboratories, LLCStock Option (Right-to-Buy)A Award	Director	AAward	+11.8K sh	—	—	11,840
2016-08-19	Impax Laboratories, LLCA Award	Director	AAward	+4,895 sh	—	—	4,895
2016-06-29	ACRSAclaris Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,632 sh	—	—	6,632
2016-05-06	MEDIVATION, INC.S Sale	CFO (former)	SSale	−400 sh	$60.66	−$24.3K	28,744
2016-05-06	MEDIVATION, INC.S Sale	CFO (former)	SSale	−5,915 sh	$60.08	−$355K	29,144
2016-05-05	MEDIVATION, INC.S Sale	CFO (former)	SSale	−4,025 sh	$59.20	−$238K	35,059
2016-03-04	MEDIVATION, INC.S Sale	CFO (former)	SSale	−1,123 sh	$40.00	−$44.9K	40,959
2016-03-04	MEDIVATION, INC.S Sale	CFO (former)	SSale	−1,875 sh	$40.00	−$75K	39,084
2016-02-29	MEDIVATION, INC.Stock Option (Right to Buy)A Award	CFO (former)	AAward	+51.4K sh	—	—	51,380
2016-02-18	MEDIVATION, INC.A Award	CFO (former)	AAward	+12.4K sh	—	—	42,082
2015-10-06	ACRSAclaris Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.8K sh	—	—	17,800
2015-05-20	MEDIVATION, INC.S Sale	CFO (former)	SSale	−1,000 sh	$130.00	−$130K	14,841
2015-05-08	MEDIVATION, INC.S Sale	CFO (former)	SSale	−385 sh	$125.00	−$48.1K	15,841
2015-05-05	MEDIVATION, INC.S Sale	CFO (former)	SSale	−1,615 sh	$125.00	−$202K	16,226
2015-05-04	MEDIVATION, INC.S Sale	CFO (former)	SSale	−2,170 sh	$124.70	−$271K	17,841
2015-04-15	MEDIVATION, INC.Stock Option (Right to Buy)M Exercise/Conversion	CFO (former)	MExercise/Conversion	−3,000 sh	—	—	28,023
2015-04-15	MEDIVATION, INC.S Sale	CFO (former)	SSale	−3,000 sh	$132.20	−$397K	20,011
2015-04-15	MEDIVATION, INC.M Exercise/Conversion	CFO (former)	MExercise/Conversion	+3,000 sh	$58.10	+$174K	23,011
2015-02-17	MEDIVATION, INC.Stock Option (Right to Buy)A Award	CFO (former)	AAward	+25K sh	—	—	25,000
2015-02-09	MEDIVATION, INC.A Award	CFO (former)	AAward	+4,500 sh	—	—	20,011

Recent filings

Accepted (ET)
Oct 164
Bierly Rick0001104659-17-062322
SEC(opens sec.gov)
Jun 164
Aclaris Therapeutics, Inc.0001209191-17-040674
SEC(opens sec.gov)
May 174
IMPAX LABORATORIES INC0001003642-17-000051
SEC(opens sec.gov)
Aug 224
IMPAX LABORATORIES INC0001003642-16-000026
SEC(opens sec.gov)
Jul 14
Aclaris Therapeutics, Inc.0001209191-16-130488
SEC(opens sec.gov)
May 94
MEDIVATION, INC.0001209191-16-118533
SEC(opens sec.gov)
Mar 74
MEDIVATION, INC.0001209191-16-106790
SEC(opens sec.gov)
Mar 24
MEDIVATION, INC.0001209191-16-104901
SEC(opens sec.gov)
Oct 64
Aclaris Therapeutics, Inc.0001209191-15-074446
SEC(opens sec.gov)
May 204
MEDIVATION, INC.0001209191-15-045036
SEC(opens sec.gov)
May 124
MEDIVATION, INC.0001209191-15-041971
SEC(opens sec.gov)
May 64
MEDIVATION, INC.0001209191-15-039619
SEC(opens sec.gov)
Apr 164
MEDIVATION, INC.0001209191-15-034651
SEC(opens sec.gov)

Companies

Address

C/O MEDIVATION, INC. 525 MARKET ST., 36TH FLOOR

SAN FRANCISCO, CA, 94105